Latest News and Press Releases

EXTON, PA, June 04, 2025 (GLOBE NEWSWIRE) -- Despite the promise of new curative strategies for beta thalassemia, such as Casgevy (Vertex) and Zynteglo (bluebird bio), most transfusion-dependent...

BioNTechs bispezifischer PD-L1xVEGF-Antikörper BNT327 ist ein Immuntherapiekandidat in der fortgeschrittenen klinischen Entwicklung, der das Potenzial hat für verschiedene Tumorarten einen neuen...

BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new...

The program, licensed exclusively to BMS, represents the third ADC candidate using the company’s proprietary Tubutecan technology to reach the clinic.  MUNICH, GERMANY, May 20, 2025 – Tubulis today...

Santa Ana, CA., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Tipmefast, Inc. (OTC: TMEF) today announced that Lucent, Inc. (“Lucent” or the “Company”), its wholly owned subsidiary, continues to expand its role...

San Francisco, CA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaiterra, a global leader in cutting-edge air quality monitoring solutions, announced today the launch of the Sensedge Go. This groundbreaking...

San Francisco, CA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Kaiterra, a global leader in cutting-edge air quality monitoring solutions, announced today the launch of the Sensedge Go. This groundbreaking...

Exton, Pennsylvania, March 22, 2024 (GLOBE NEWSWIRE) -- The end of 2023 introduced several new treatment options for patients suffering from ulcerative colitis (UC). Among them is Eli Lilly’s Omvoh...

Company in full commercial EV production with Class 1 and Class 3 vehicles; Bollinger Motors focused on Class 4-6 vehicles with Class 4 production starting in second half 2024   Company achieves...

Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading Oncology...